Correspondence — the editorial register

Editorial correspondence

Safe KLOW is an independent editorial archive. We accept correspondence on the following matters:

• Citation corrections. If a cited study has been retracted, substantially corrected, or its PMID/DOI has changed, please flag it. The integrity of the accession record depends on accurate identifiers.
• Research updates. If a significant peer-reviewed study on KPV, GHK-Cu, BPC-157, or TB-500 has been published that is not indexed here, we are interested.
• Editorial questions. Questions about why specific findings are characterized as they are, or about the editorial principles governing component attribution and the absent-blend-data policy.

This archive does not respond to the following: product sourcing inquiries, requests for dosing guidance, clinical advice, or vendor referrals. The archive is not affiliated with any supplier or commercial entity in the KLOW peptide space.

Use the form below for all correspondence. Responses are provided on an editorial timeline — typically within five to seven business days for substantive inquiries.